EPAS1 and neoplasm: An intraperitoneal injection of TMZ (2 mg/kg) into the aforementioned groups reduced the tumour volume in the HIF1α or HIF2α knockout groups, and the smallest tumour volume was observed in the group with dual HIF1α and HIF2α knockout (Fig. 3i.